Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AGEN
AGEN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AGEN News
New Therapy Shows Significant Efficacy in Gastroesophageal Cancer
2d ago
Newsfilter
Agenus Shows Remarkably Improving Earnings Outlook
Apr 03 2026
NASDAQ.COM
Zacks Premium Empowers Confident Investing for All
Apr 03 2026
NASDAQ.COM
Agenus Launches Landmark Global Phase 3 Clinical Trial
Apr 01 2026
Newsfilter
Agenus Hosts 2026 Stakeholder Webcast on Immunotherapy Progress
Mar 26 2026
Newsfilter
Agenus Introduces Novel Immunotherapy to Extend Survival
Mar 17 2026
Newsfilter
Agenus Surpasses Earnings and Revenue Expectations
Mar 17 2026
NASDAQ.COM
Agenus Expands Global Early Access Programs for BOT+BAL
Mar 16 2026
Newsfilter
Agenus to Announce Q4 Earnings on March 16
Mar 13 2026
seekingalpha
GSK's Arexvy Vaccine Label Expansion Approved by FDA
Mar 13 2026
seekingalpha
Agenus Triggers First $20M Payment in Zydus Collaboration
Mar 10 2026
seekingalpha
Agenus Triggers First Payment in Zydus Collaboration
Mar 10 2026
Newsfilter
Agenus to Release Q4 and Year-End 2025 Financial Results
Mar 04 2026
Businesswire
Agenus Announces Q4 and Year-End 2025 Financial Results Release
Mar 04 2026
Newsfilter
Agenus Unveils New Clinical Data on Botensilimab and Balstilimab
Feb 19 2026
Businesswire
Agenus' New Therapy Significantly Improves Survival Rates in Cancer Patients
Feb 19 2026
Newsfilter
Show More News
